Essential Line from ZEISS

Article

Simplicity in basic diagnostics

The new ZEISS Essential Line portfolio of basic diagnostic instruments brings simplicity to your examination workflows – and quality right from the start.

  • Objective refraction

  • IOP and retina screening

  • Slit lamp examination

  • Subjective refraction

Smartly optimize your diagnostic workflow

  • Modular, easily expandable portfolio of basic diagnostic devices

  • Customizable solutions for all practice infrastructures – from single device to complete practice setup, including furnishings

  • DICOM compatibility and clearly defined interfaces for EMR/EHR and PACS

  • Renowned ZEISS quality at an affordable price

  • Comprehensive ZEISS service offerings for quick support and for smooth practice processes

Find out more: www.meditec.zeiss.com/essential-line Contact us: www.meditec.zeiss.com/contacts

 

 

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
From left: Maria Vittoria Cicinelli, MD; Denise Loya-Garcia, MD, PhD; Vishal Raval, MD. Images courtesy of ARVO.

Three researchers receive 2025 ARVO Foundation Early Career Clinician-Scientist Awards

Martin David Harp
March 18th 2025
Article

The award recipients are leading research projects in India, Italy and Mexico

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
Images of a chest X-ray and a CT scan show the chest and vascular system following a COVID-19 infection. Image credit: ©samunella – stock.adobe.com

EDI-OCT and CVI findings can shed light on choroidal vascular physiology following COVID-19 pneumonia

Lynda Charters
March 17th 2025
Article

Investigators measured the choroidal structures using enhanced depth imaging optical coherence tomography

An image of the old town in Winterthur, Switzerland, showing buildings and clock towers. Image credit: ©bill_17 – stock.adobe.com

Winterthur, Switzerland welcomes second annual Winterthur Ophthalmology Symposium

Hattie Hayes
March 14th 2025
Article

After a successful inaugural WOS in 2024, the congress will feature new lectures and wetlabs in its sophomore year

An eye doctor administers cyclosporine eye drops to a patient. Image credit: ©smile35 – stock.adobe.com

Study assesses efficacy of cyclosporine A 0.1% cationic emulsion drops for postoperative discomfort

Lynda Charters
March 14th 2025
Article

Prophylactic cyclosporine A 0.1% eye drops were associated with improved ocular surface homeostasis and reduced inflammation

Wooden blocks which say PHASE and a block at the end with the numbers 1/2. The last block is switching from 1 to 2. This represents a clinical trial moving through phases. Image credit: ©rabbitti – stock.adobe.com

First patient dosed in Phase 1/2 ASTRA study for Stargardt disease therapy SB-007 (SpliceBio)

Hattie Hayes
March 13th 2025
Article

SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial

© 2025 MJH Life Sciences

All rights reserved.